213 related articles for article (PubMed ID: 17505590)
1. [Mutation in LRRK2 is associated with familial presentation of Parkinson's disease in a Chilean kindred].
Miranda M
Rev Med Chil; 2007 Mar; 135(3):406-7. PubMed ID: 17505590
[No Abstract] [Full Text] [Related]
2. [Pathogenesis of Parkinson's disease through LRRK2 mutation].
Ohta E; Obata F
Seikagaku; 2014 Feb; 86(1):92-7. PubMed ID: 24693706
[No Abstract] [Full Text] [Related]
3. Lrrk2 mutations in South America: A study of Chilean Parkinson's disease.
Perez-Pastene C; Cobb SA; Díaz-Grez F; Hulihan MM; Miranda M; Venegas P; Godoy OT; Kachergus JM; Ross OA; Layson L; Farrer MJ; Segura-Aguilar J
Neurosci Lett; 2007 Jul; 422(3):193-7. PubMed ID: 17614198
[TBL] [Abstract][Full Text] [Related]
4. Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease.
Nichols WC; Pankratz N; Hernandez D; Paisán-Ruíz C; Jain S; Halter CA; Michaels VE; Reed T; Rudolph A; Shults CW; Singleton A; Foroud T;
Lancet; 2005 Jan 29-Feb 4; 365(9457):410-2. PubMed ID: 15680455
[TBL] [Abstract][Full Text] [Related]
5. Association of LRRK2 and GBA mutations in a Brazilian family with Parkinson's disease.
Spitz M; Pereira JS; Nicareta DH; Abreu Gde M; Bastos EF; Seixas TL; Pimentel MM
Parkinsonism Relat Disord; 2015 Jul; 21(7):825-6. PubMed ID: 25952961
[No Abstract] [Full Text] [Related]
6. A study of LRRK2 mutations and Parkinson's disease in Brazil.
Pimentel MM; Moura KC; Abdalla CB; Pereira JS; de Rosso AL; Nicaretta DH; Campos M; de Almeida RM; dos Santos JM; Bastos IC; Mendes MF; Maultasch H; Costa FH; Werneck AL; Santos-Rebouças CB
Neurosci Lett; 2008 Mar; 433(1):17-21. PubMed ID: 18201824
[TBL] [Abstract][Full Text] [Related]
7. A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations.
Zabetian CP; Samii A; Mosley AD; Roberts JW; Leis BC; Yearout D; Raskind WH; Griffith A
Neurology; 2005 Sep; 65(5):741-4. PubMed ID: 16157909
[TBL] [Abstract][Full Text] [Related]
8. The biology and pathobiology of LRRK2: implications for Parkinson's disease.
Moore DJ
Parkinsonism Relat Disord; 2008; 14 Suppl 2():S92-8. PubMed ID: 18602856
[TBL] [Abstract][Full Text] [Related]
9. LRRK2: both a cause and a risk factor for Parkinson disease?
Foroud T
Neurology; 2005 Sep; 65(5):664-5. PubMed ID: 16157895
[No Abstract] [Full Text] [Related]
10. Pathogenicity of the Lrrk2 R1514Q substitution in Parkinson's disease.
Toft M; Mata IF; Ross OA; Kachergus J; Hulihan MM; Haugarvoll K; Stone JT; Blazquez M; Gibson JM; Aasly JO; White LR; Lynch T; Adler CH; Gwinn-Hardy K; Farrer MJ
Mov Disord; 2007 Feb; 22(3):389-92. PubMed ID: 17216639
[TBL] [Abstract][Full Text] [Related]
11. Clinical and positron emission tomography of Parkinson's disease caused by LRRK2.
Hernandez DG; Paisán-Ruíz C; McInerney-Leo A; Jain S; Meyer-Lindenberg A; Evans EW; Berman KF; Johnson J; Auburger G; Schäffer AA; Lopez GJ; Nussbaum RL; Singleton AB
Ann Neurol; 2005 Mar; 57(3):453-6. PubMed ID: 15732108
[TBL] [Abstract][Full Text] [Related]
12. Clinical features of LRRK2-associated Parkinson's disease in central Norway.
Aasly JO; Toft M; Fernandez-Mata I; Kachergus J; Hulihan M; White LR; Farrer M
Ann Neurol; 2005 May; 57(5):762-5. PubMed ID: 15852371
[TBL] [Abstract][Full Text] [Related]
13. A novel P755L mutation in LRRK2 gene associated with Parkinson's disease.
Wu T; Zeng Y; Ding X; Li X; Li W; Dong H; Chen S; Zhang X; Ma G; Yao J; Deng X
Neuroreport; 2006 Dec; 17(18):1859-62. PubMed ID: 17179858
[TBL] [Abstract][Full Text] [Related]
14. The ancestry of LRRK2 Gly2019Ser parkinsonism.
Benamer HT
Lancet Neurol; 2008 Sep; 7(9):769-70; author reply 770-1. PubMed ID: 18702998
[No Abstract] [Full Text] [Related]
15. Low disease risk in relatives of north african lrrk2 Parkinson disease patients.
Troiano AR; Elbaz A; Lohmann E; Belarbi S; Vidailhet M; Bonnet AM; Lesage S; Pollak P; Cazeneuve C; Borg M; Feingold J; Dürr A; Tazir M; Brice A;
Neurology; 2010 Sep; 75(12):1118-9. PubMed ID: 20855856
[No Abstract] [Full Text] [Related]
16. LRRK2: bridging the gap between sporadic and hereditary Parkinson's disease.
Elbaz A
Lancet Neurol; 2008 Jul; 7(7):562-4. PubMed ID: 18539536
[No Abstract] [Full Text] [Related]
17. Comprehensive screening of a North American Parkinson's disease cohort for LRRK2 mutation.
Johnson J; Paisán-Ruíz C; Lopez G; Crews C; Britton A; Malkani R; Evans EW; McInerney-Leo A; Jain S; Nussbaum RL; Foote KD; Mandel RJ; Crawley A; Reimsnider S; Fernandez HH; Okun MS; Gwinn-Hardy K; Singleton AB
Neurodegener Dis; 2007; 4(5):386-91. PubMed ID: 17622782
[TBL] [Abstract][Full Text] [Related]
18. LRRK2 in Parkinson's disease - drawing the curtain of penetrance: a commentary.
Krüger R
BMC Med; 2008 Nov; 6():33. PubMed ID: 18986509
[TBL] [Abstract][Full Text] [Related]
19. G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort.
Bras JM; Guerreiro RJ; Ribeiro MH; Januario C; Morgadinho A; Oliveira CR; Cunha L; Hardy J; Singleton A
Mov Disord; 2005 Dec; 20(12):1653-5. PubMed ID: 16149095
[TBL] [Abstract][Full Text] [Related]
20. Mutations in LRRK2 as a cause of Parkinson's disease.
Giasson BI; Van Deerlin VM
Neurosignals; 2008; 16(1):99-105. PubMed ID: 18097165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
